# name
Ivermectin to reduce malaria transmission III. Considerations
                regarding regulatory and policy pathways

# metadata.dc.description.abstract[].value
Vector control is a task previously relegated to products that
                (a) kill the mosquitoes directly at different stages
                (insecticides, larvicides, baited traps), or (b) avoid/reduce
                human-mosquito contact (bed nets, repellents, house screening),
                thereby reducing transmission. The potential community-based
                administration of the endectocide ivermectin with the intent to
                kill mosquitoes that bite humans, and thus reduce malaria
                transmission, offers a novel approach using a well-known drug,
                but additional steps are required to address technical,
                regulatory and policy gaps. The proposed community
                administration of this drug presents dual novel paradigms;
                first, indirect impact on the community rather than on
                individuals, and second, the use of a drug for vector control.
                In this paper, the main questions related to the regulatory and
                policy pathways for such an application are identified. Succinct
                answers are proposed for how the efficacy, safety,
                acceptability, cost-effectiveness and programmatic suitability
                could result in regulatory approval and ultimately policy
                recommendations on the use of ivermectin as a complementary
                vector control tool.

# metadata.dc.source[].value
Articles publicats en revistes (ISGlobal)

# metadata.dc.title[].value
Ivermectin to reduce malaria transmission III. Considerations
                regarding regulatory and policy pathways